Navigation Links
Pacific Shore Holdings, Inc. Receives Symbol Change Approval From FINRA
Date:2/14/2011

LOS ANGELES, Feb 14, 2011 /PRNewswire/ -- Pacific Shore Holdings, Inc. (previously Green Shores, Inc.), a Delaware corporation, announced today that management has received approval from the Financial Industry Regulatory Authority ("FINRA") for the change of its symbol to "PSHR.PK" from "GSHR.PK". "We are excited about the symbol change, as it takes us one step closer to completion of our planned entrance into the Public Markets. "Once we enter the Public Marketplace, we believe that we will be in position to attract significant capital infusions from a multitude of Market players," states Pacific Shore Holdings, Inc. Chief Financial Officer Ronald J. Tchorzewski.

Building on its corporate governance, Pacific Shore Holdings, Inc. also announced today that it has appointed Matthew A. Mills as Chairman of the Board, President and Chief Executive Officer of the Company replacing Dr. David E. Toomey who will remain as a Director of the Company as well as Executive Vice President. In addition, Mr. Mills announced the appointments of Ronald J. Tchorzewski as Chief Financial Officer and Director, Jennifer Mills as Corporate Secretary and Director and Dr. Allan Kurtz as a Director. "I am pleased with these appointments as each individual brings with them valuable experience and expertise to help take our Company to the next level. Our multiple brands and products have shown a very positive response from consumers around the world during our test marketing programs. I believe we will now be poised to secure the financial resources necessary to begin aggressive product marketing campaigns nationally and internationally to successfully expand our operations," states President and Chief Executive Officer Matthew Mills.

About Pacific Shore Holdings, Inc.: Pacific Shore Holdings, Inc. is a Delaware corporation whose dormant common stock has a trading symbol on the Pink Sheets of "PSHR.PK" which was previously "GSHR.PK". For more information, contact Pacific Shore Holdings, Inc. at info@pac-sh.com or (818) 998-0996.

Forward-Looking Statements: Certain statements in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) and accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events.


'/>"/>
SOURCE Pacific Shore Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Pacific Biosciences and Harvard scientists decode genome of Haitian cholera pathogen
2. Asia Pacific Flexible Alternating Current Transmission Equipment Markets
3. BioProcess International Launches Monthly Asia-Pacific eNewsletter
4. Sundia Named Deloitte Technology Fast 500 Asia Pacific for 2nd Consecutive Year
5. OncoGenex Pharmaceuticals CEO Named Canadas Pacific Ernst & Youngs Entrepreneur Of The Year(R) in the Health Sciences Category
6. Hugh Tilson Receives Leadership Award at Pacific Drug Safety Summit
7. Pacific Biometrics Completes $4 Million Debt Financing
8. Pacific Health Research Institute Awarded $2.8 Million in Research Funding
9. Pacific Health Research Institute Awarded $2.8 Million in Research Funding
10. PacificGMP and USC to Collaborate on Recombinant Protein Development and Manufacturing for Phase 1 Clinical Trial
11. Avantium to Deliver Flowrence System to Pacific Northwest National Laboratory (PNNL), USA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... , ... July 20, 2017 , ... ... to make clinical trial sites and study participants truly unified. TrialKit, a native ... (FDA 21 CFR Part 11) research studies entirely on mobile devices. With TrialKit, ...
(Date:7/18/2017)... ... , ... G-CON today announced that it has received Notices ... Applications 14/858,857 and 13/669,785 both entitled Modular, Self-Contained, Mobile Clean Room. The U.S. ... of G-CON’s R&D investments and validate the G-CON platform as a novel way ...
(Date:7/17/2017)... ... , ... Whitehouse Laboratories is excited to announce that it ... of ISO 80369 standard test procedures. The ISO 80369 series of eight test ... With this recent expansion, Whitehouse Labs becomes one of the only facilities in ...
(Date:7/17/2017)... ... July 17, 2017 , ... Neurodevelopmental disorders (NDDs) are ... overlapping clinical features. The advancement of targeted next-generation sequencing (NGS) has been instrumental ... testing. , However, designing a custom panel for disease research requires hours ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 No ... but researchers at the New York University Tandon ... of Engineering have found that partial similarities between ... systems used in mobile phones and other electronic ... The vulnerability lies in the fact ...
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
Breaking Biology News(10 mins):